Schulzer M

References (1)

Title : The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study - Liu_2018_Lancet.Neurol_17_309

Author(s) : Liu SY , Wile DJ , Fu JF , Valerio J , Shahinfard E , McCormick S , Mabrouk R , Vafai N , McKenzie J , Neilson N , Perez-Soriano A , Arena JE , Cherkasova M , Chan P , Zhang J , Zabetian CP , Aasly JO , Wszolek ZK , McKeown MJ , Adam MJ , Ruth TJ , Schulzer M , Sossi V , Stoessl AJ

Ref : Lancet Neurol , 17 :309 , 2018

Abstract :

PubMedSearch : Liu_2018_Lancet.Neurol_17_309

PubMedID: 29456161

Schulzer M

References (1)

1. The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study - Liu_2018_Lancet.Neurol_17_309